Decade-long Application of Preimplantation Genetic Testing for DMD/BMD: Analysis of Five Clinical Strategies and Embryo Recombination Patterns

Overview

Journal Hum Genet

Specialty Genetics

Date 2025 Feb 19

PMID 39969580

Authors

Weili Wang

Jing Dai

Xiao Hu

Wenbin He

Yifan Gu

Zhenxing Wan

Yi Zhang

Keli Luo

Wen Li

Qianjun Zhang

Fei Gong

Guangxiu Lu

Liang Hu

Yue-Qiu Tan

Ge Lin

Juan Du

Affiliations

Soon will be listed here.

Abstract

This study aimed to find the most effective PGT-M strategy for Duchenne muscular dystrophy/Becker muscular dystrophy (DMD/BMD), and to reduce misdiagnosis caused by embryo recombination in DMD. A retrospective study was performed by analyzing 158 PGT-M cycles for DMD/BMD in Reproductive and Genetic Hospital of CITIC-Xiangya between 2009 and 2023. Patients' backgrounds were collected. The effectiveness and safety for five different PGT-M strategies (1-5), including mutation testing from cleavage or trophoblast ectoderm (TE) cells and additional linkage analysis post-TE cell amplification, were analyzed. The embryonic recombination events were assessed for these cycles. Mutation analysis showed that 62.4% of the 125 families had DMD deletions, 16.0% had duplications, and 21.6% had single nucleotide variants (SNVs). Among 125 families, 104 (83.2%) had previously affected fetus or offspring. The highest diagnosis rate (99.56%) was achieved with Strategy 5, which combined mutation testing with SNP-based linkage analysis in TE cells. This strategy 5 also demonstrated an advantage in cases with recombination near the mutation. An intragenic recombination rate of 5.5% was observed in embryos, predominantly in the hotspots (exons 45-55 and exons 3-9) of DMD deletion/duplication mutations. Prenatal diagnosis for 52 families and successful outcomes in all 85 healthy deliveries (live birth rate, 65.89%, 85/129) validated the accuracy and effectiveness of PGT-M. This study provides a highly effective PGT-M strategy (Strategy 5) for DMD/BMD by comparing five different strategies, with the diagnostic yield reaching 99.56%. The results underscore the significance of monitoring intragenic recombination in DMD, which is a frequent occurrence in DMD/BMD.

References

Abbs S, Roberts R, Mathew C, Bentley D, Bobrow M . Accurate assessment of intragenic recombination frequency within the Duchenne muscular dystrophy gene. Genomics. 1990; 7(4):602-6. DOI: 10.1016/0888-7543(90)90205-9. View

Birnkrant D, Bushby K, Bann C, Alman B, Apkon S, Blackwell A . Diagnosis and management of Duchenne muscular dystrophy, part 2: respiratory, cardiac, bone health, and orthopaedic management. Lancet Neurol. 2018; 17(4):347-361. PMC: 5889091. DOI: 10.1016/S1474-4422(18)30025-5. View

Capalbo A, Valero R, Jimenez-Almazan J, Mir Pardo P, Fabiani M, Jimenez D . Optimizing clinical exome design and parallel gene-testing for recessive genetic conditions in preconception carrier screening: Translational research genomic data from 14,125 exomes. PLoS Genet. 2019; 15(10):e1008409. PMC: 6797235. DOI: 10.1371/journal.pgen.1008409. View

Capalbo A, Fabiani M, Caroselli S, Poli M, Girardi L, Patassini C . Clinical validity and utility of preconception expanded carrier screening for the management of reproductive genetic risk in IVF and general population. Hum Reprod. 2021; 36(7):2050-2061. DOI: 10.1093/humrep/deab087. View

Chen J, Hejtmancik J, Romeo G, Lindlof M, Boehm C, Caskey C . A genetic linkage map of five marker loci in and around the Duchenne muscular dystrophy locus. Genomics. 1989; 4(1):105-9. DOI: 10.1016/0888-7543(89)90322-4. View

De Rycke M, Berckmoes V . Preimplantation Genetic Testing for Monogenic Disorders. Genes (Basel). 2020; 11(8). PMC: 7463885. DOI: 10.3390/genes11080871. View

Duan D, Goemans N, Takeda S, Mercuri E, Aartsma-Rus A . Duchenne muscular dystrophy. Nat Rev Dis Primers. 2021; 7(1):13. PMC: 10557455. DOI: 10.1038/s41572-021-00248-3. View

Harton G, De Rycke M, Fiorentino F, Moutou C, Sengupta S, Traeger-Synodinos J . ESHRE PGD consortium best practice guidelines for amplification-based PGD. Hum Reprod. 2010; 26(1):33-40. DOI: 10.1093/humrep/deq231. View

Hu X, He W, Zhang S, Luo K, Gong F, Dai J . Next-generation sequence-based preimplantation genetic testing for monogenic disease resulting from maternal mosaicism. Mol Genet Genomic Med. 2021; 9(5):e1662. PMC: 8172198. DOI: 10.1002/mgg3.1662. View

10.

Hu X, Wang W, Luo K, Dai J, Zhang Y, Wan Z . Extended application of PGT-M strategies for small pathogenic CNVs. J Assist Reprod Genet. 2024; 41(3):739-750. PMC: 10957852. DOI: 10.1007/s10815-024-03028-6. View

11.

Huang L, Ma F, Chapman A, Lu S, Xie X . Single-Cell Whole-Genome Amplification and Sequencing: Methodology and Applications. Annu Rev Genomics Hum Genet. 2015; 16:79-102. DOI: 10.1146/annurev-genom-090413-025352. View

12.

Kong X, Zhong X, Liu L, Cui S, Yang Y, Kong L . Genetic analysis of 1051 Chinese families with Duchenne/Becker Muscular Dystrophy. BMC Med Genet. 2019; 20(1):139. PMC: 6694523. DOI: 10.1186/s12881-019-0873-0. View

13.

Konstantinidis M, Ravichandran K, Gunes Z, Prates R, Goodall N, Roman B . Aneuploidy and recombination in the human preimplantation embryo. Copy number variation analysis and genome-wide polymorphism genotyping. Reprod Biomed Online. 2020; 40(4):479-493. DOI: 10.1016/j.rbmo.2019.12.008. View

14.

Lee I, Alur-Gupta S, Gallop R, Dokras A . Utilization of preimplantation genetic testing for monogenic disorders. Fertil Steril. 2020; 114(4):854-860. DOI: 10.1016/j.fertnstert.2020.05.045. View

15.

Lin J, Li H, Liao Z, Wang L, Zhang C . Comparison of Carrier and Pathogenic Variants in a Chinese DMD/BMD Cohort. Front Neurol. 2021; 12:714677. PMC: 8375267. DOI: 10.3389/fneur.2021.714677. View

16.

Luo S, He W, Zhao X, Yang X, Gao B, Li S . [Genetic testing and prenatal diagnosis of 671 Chinese pedigrees affected with Duchenne/Becker muscular dystrophy]. Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2022; 39(9):925-931. DOI: 10.3760/cma.j.cn511374-20210911-00744. View

17.

Ma S, Liao J, Zhang S, Yang X, Hocher B, Tan J . Exploring the efficacy and beneficial population of preimplantation genetic testing for aneuploidy start from the oocyte retrieval cycle: a real-world study. J Transl Med. 2023; 21(1):779. PMC: 10623718. DOI: 10.1186/s12967-023-04641-2. View

18.

Ma L, Yang C, Xiao D, Liu X, Jiang X, Lin H . Chromosome-level assembly of Dictyophora rubrovolvata genome using third-generation DNA sequencing and Hi-C analysis. G3 (Bethesda). 2023; 13(8). PMC: 10411574. DOI: 10.1093/g3journal/jkad102. View

19.

Monaco A, Walker A, Millwood I, Larin Z, Lehrach H . A yeast artificial chromosome contig containing the complete Duchenne muscular dystrophy gene. Genomics. 1992; 12(3):465-73. DOI: 10.1016/0888-7543(92)90436-v. View

20.

Mukherjee M, Chaturvedi L, Srivastava S, Mittal R, Mittal B . De novo mutations in sporadic deletional Duchenne muscular dystrophy (DMD) cases. Exp Mol Med. 2003; 35(2):113-7. DOI: 10.1038/emm.2003.16. View